September 2022 News & Views: Reserve Your Spot for the AMCP Summit on Value and Access; Join Your Colleagues in National Harbor, Md. For Nexus 2022; AMCP Summit on Addressing Health Disparities: Top 10 Takeaways; Join AMCP Foundation’s 5K For the Future During Nexus 2022.
On Dec. 2, the Centers for Medicare and Medicaid Services (CMS) issued a Request for Information (RFI) on Essential Health Benefits (EHB). The RFI sought input on a proposed switch to the U.S. Pharmacopeia Drug Classification (USP DC) standard for defining the EHB prescription drug category. AMCP's comments, submitted on Jan. 31, urge CMS to refrain from switching to any alternative prescription drug classification standard.
AMCP's volunteers are vital players in propelling our mission forward. In this installment of the AMCP Volunteer Spotlight, we are featuring Brenden O'Hara, RPh, BCACP, Carolinas AMCP President, Diplomat, and Professional Practice Committee member.
On Dec. 21, the Department of Health and Human Services released a proposed rule titled "Patient Protection and Affordable Care Act, HHS Notice of Benefit and Payment Parameters for 2024." On Jan. 30, AMCP submitted comments which oppose two issues from the proposed rule; continuing formulary tier limitations for standardized plan options and new limits on the number of non-standardized plan options that issues may offer through the federal Marketplace.
On Jan. 27, AMCP, along with 76 other healthcare organizations, signed on to a consensus statement on health equity. In the statement, signatories recognize health inequity as a complex issue and reaffirm their commitment to take action within their organizations to reduce health inequities for the broader population.
In the world of health care innovation, speed matters. But when it comes to developing and deploying cutting-edge treatments and therapeutics safely, a cautious and methodical approach is vital as well. Safety matters as much as speed, but faster doesn’t always mean riskier. In her latest blog, AMCP CEO Susan Cantrell discusses the history of the Pre-approval Information Exchange (PIE) Act and how it will help patients.
January 2023 Legislative & Regulatory Briefing: The PIE Act of 2022 Becomes Law; Member Benefit! Stay Up to Date on IRA Guidance with Regulatory NewsBREAKs; Media Coverage Captures Its Own Piece of the PIE; Reimbursement for PDTs Could Increase Access to Emerging Treatments; Registration is Now Open for AMCP 2023 in San Antonio.